Myeloperoxidase predicts risk of vasculopathic events in hemizgygous males with Fabry disease
- 12 December 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 67 (11) , 2045-2047
- https://doi.org/10.1212/01.wnl.0000247278.88077.09
Abstract
Fabry disease results in a global vasculopathy leading to early-onset stroke and renal and cardiac failure. We found that random myeloperoxidase in serum and plasma was significantly elevated in 73 consecutive male patients with Fabry disease. Random serum myeloperoxidase level in men predicted the risk of a Fabry vasculopathy–related event in subsequent years. Long-term enzyme replacement therapy did not reduce myeloperoxidase level or eliminate the risk of vasculopathic events.Keywords
This publication has 11 references indexed in Scilit:
- Pathological findings in a patient with Fabry disease who died after 2.5 years of enzyme replacementVirchows Archiv, 2005
- Long-term therapy with agalsidase alfa for Fabry disease: safety and effects on renal function in a home infusion settingNephrology Dialysis Transplantation, 2005
- Formation of Dysfunctional High-Density Lipoprotein by MyeloperoxidaseTrends in Cardiovascular Medicine, 2005
- α-Galactosidase A Deficiency Accelerates Atherosclerosis in Mice With Apolipoprotein E DeficiencyCirculation, 2005
- Ascorbate decreases Fabry cerebral hyperperfusion suggesting a reactive oxygen species abnormality: An arterial spin tagging studyJournal of Magnetic Resonance Imaging, 2004
- White matter lesions in Fabry disease occur in ‘prior’ selectively hypometabolic and hyperperfused brain regionsBrain Research Bulletin, 2003
- Serum myeloperoxidase concentration in a healthy population: biological variations, familial resemblance and new genetic polymorphismsEuropean Journal of Human Genetics, 2001
- Regional Cerebral Hyperperfusion and Nitric Oxide Pathway Dysregulation in Fabry DiseaseCirculation, 2001
- Clinical Features of and Recent Advances in Therapy for Fabry DiseaseJAMA, 2000
- Profile of endothelial and leukocyte activation in fabry patientsAnnals of Neurology, 2000